Home
Moxtas CV Paediatric Dry Syrup 3.3 gm/30 ml
Moxtas CV Paediatric Dry Syrup 3.3 gm/30 ml Substitute

Moxtas CV Paediatric Dry Syrup 3.3 gm/30 ml Substitute

Drivebact 228.5 mg Dry Syrup 30 ml

by Others

₹1.80per tablet

Verified Ingredients and Effects

Composition:

AMOXYCILLIN-200MG + CLAVULANIC ACID-28.5MG

Uses:

Moxtas CV Paediatric Dry Syrup 3.3 gm/30 ml is used in the treatment of bacterial infections in children. The detailed uses of Moxtas CV Paediatric Dry Syrup 3.3 gm/30 ml are as follows:<ul><li>Treating Bacterial Infections: Moxtas CV Paediatric Dry Syrup 3.3 gm/30 ml treats various bacterial infections in children, including respiratory tract infections and ear infections, with its antibiotic properties.</li><li>Sinusitis Management: Moxtas CV Paediatric Dry Syrup 3.3 gm/30 ml helps to manage sinusitis by treating bacterial infections that cause sinus inflammation, alleviating symptoms like facial pain and congestion.</li><li>Skin Infections: Moxtas CV Paediatric Dry Syrup 3.3 gm/30 ml is used in treating skin and soft tissue infections by targeting and eliminating the bacteria that cause the infection.</li><li>Urinary Tract Infections: Moxtas CV Paediatric Dry Syrup 3.3 gm/30 ml is indicated for treating urinary tract infections (UTIs) by targeting the bacteria causing the infection, providing relief from symptoms, and supporting recovery.</li><li>Dental Infections: Moxtas CV Paediatric Dry Syrup 3.3 gm/30 ml is also used in the treatment of dental infections, including dental abscesses and oral infections, promoting healing and relieving pain.</li></ul>

Medicinal Benefits:

Moxtas CV Paediatric Dry Syrup 3.3 gm/30 ml is a combination medicine containing Amoxycillin and Clavulanic acid. It is a broad-spectrum penicillin-type antibiotic that acts against both aerobic (grow in the presence of oxygen) and anaerobic (grow in the absence of oxygen) bacteria. Moxtas CV Paediatric Dry Syrup 3.3 gm/30 ml is used to treat bacterial infections in children. Moxtas CV Paediatric Dry Syrup 3.3 gm/30 ml works by inhibiting the formation of the bacterial cell wall (a protective covering) and causing damage to the bacterial cell wall. This eventually leads to the death of the bacterial cell and thus prevents the growth of bacterial infections. Clavulanic acid inhibits the beta-lactamase enzyme, which prevents bacteria from destroying the efficacy of amoxycillin.

FAQs

What is the use of Moxtas CV Paediatric Dry Syrup 3.3 gm/30 ml?

Moxtas CV Paediatric Dry Syrup 3.3 gm/30 ml is used to treat bacterial infections in children.

How does Moxtas CV Paediatric Dry Syrup 3.3 gm/30 ml work?

Moxtas CV Paediatric Dry Syrup 3.3 gm/30 ml contains amoxycillin and clavulanic acid. Amoxycillin works by inhibiting the formation of the bacterial cell wall (a protective covering) and causing damage to the bacterial cell wall. This eventually leads to the death of the bacterial cell and thus prevents the growth of bacterial infections. Clavulanic acid inhibits the beta-lactamase enzyme, which prevents bacteria from destroying the efficacy of amoxycillin.

Is Moxtas CV Paediatric Dry Syrup 3.3 gm/30 ml used to treat viral infections?

No, Moxtas CV Paediatric Dry Syrup 3.3 gm/30 ml is not used to treat viral infections. It is an antibiotic used only to treat bacterial infections.

Can we stop giving Moxtas CV Paediatric Dry Syrup 3.3 gm/30 ml if the child feel better?

No. As Moxtas CV Paediatric Dry Syrup 3.3 gm/30 ml is an antibiotic, it is advised to complete your child's entire course of treatment as prescribed. If the treatment is stopped abruptly, drug resistance may develop.